Entries by Mark Mosier

Twenty States Recognize May 17th as DIPG Awareness Day

For the first time in history, at least 20 states will recognize May 17th as Diffuse Intrinsic Pontine Glioma (DIPG) Awareness Day, to raise public awareness of the deadliest childhood brain cancer. DIPG is the leading cause of childhood death due to brain tumors and typically strikes school-age children. The “DIPG Across the Map Initiative,” […]

Michael Mosier Defeat DIPG® Foundation Expands its Board of Directors and Appoints a Scientific Advisory Council.

To kickoff Brain Tumor Awareness Month, Michael Mosier Defeat DIPG® Foundation is excited to announce that it has expanded its Board of Directors and has appointed a Scientific Advisory Council. In 2016, its first full year in operation, Michael Mosier Defeat DIPG Foundation enjoyed a successful year in raising funds for research for effective treatments for […]

Researchers Identify Potential New Treatment for DIPG

Researchers at Northwestern University have determined that a class of drugs known as BET inhibitors may provide an effective treatment for DIPG.  These researchers treated mice with BET inhibitors and found that, after ten days of treatment, the mice’s tumors were significantly smaller.  The results of these study were recently published in Nature Medicine, and has […]